American Century Companies’s Arbutus Biopharma ABUS Stock Holding History

American Century Companies's ABUS Position: Q2 2026 in Review

American Century Companies opened a new position in Arbutus Biopharma (ABUS) in Q2 2026: 66,215 shares worth $318K. The stake represents ﹤0.01% of the portfolio and ranks #2693 among its holdings. This is a return to the name: American Century Companies previously reported a position in ABUS as recently as Q3 2024.

American Century Companies first reported a position in ABUS in Q2 2018 and has held it in 8 quarters since. The position peaked at $326K in Q1 2024. 177 funds tracked by Wall St. Rank hold ABUS as of Q2 2026.

• American Century Companies held 66,215 shares of Arbutus Biopharma worth $318K as of Q2 2026.
• Arbutus Biopharma was a new American Century Companies position in Q2 2026.
• Arbutus Biopharma made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2693 holding.
• American Century Companies first reported a position in Arbutus Biopharma in Q2 2018 and has held it in 8 quarters since.
• American Century Companies's Arbutus Biopharma position peaked at $326K in Q1 2024.
• 177 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.